CHI3L1 and asthma: YKL-40, which is a biomarker of inflammation, has been widely used in clinical practice as a relatively reliable diagnostic marker in various inflammatory diseases, such as non-alcoholic steatohepatitis and liver fibrosis (28), asthma and chronic obstructive pulmonary disease (29), and chronic kidney disease (30).